Anadolu Medical Center
CyberKnife for prostate cancer in Turkey typically costs from $25,000 to $32,000. The final price depends on the number of radiation sessions and the complexity of the tumor. Patients save around 48% compared to the US, where the average cost is $55,000. Most Turkish clinics include diagnostic imaging, airport transfers, and interpreter services in their oncology packages.
Bookimed Expert Insight: Choosing a university-affiliated center like Medipol Mega or Anadolu Medical Center provides high-tier security. These clinics are accredited by JCI and OECI, ensuring international safety standards. Medipol Mega typically offers CyberKnife sessions for approximately $8,250, including treatment planning. Anadolu Medical Center provides extra value through its affiliation with Johns Hopkins Hospital. For those seeking cost-effective options, Memorial Şişli offers packages starting around $5,750. This generally includes the procedure, transfers, and medical translation services.
Why choose Turkey for CyberKnife treatment for prostate cancer?
Access advanced CyberKnife for prostate cancer solutions in trusted clinics .
| Turkey | Austria | Spain | |
| CyberKnife for prostate cancer | from $25,000 | from $25,000 | from $15,000 |
Day 1: Arrival
Day 2: Pre-Operation
Day 3: Rest Day
Day 4: CyberKnife Treatment
Day 5: Post-Treatment
Day 6: Discharge
Week 1-2: Rehabilitation
Week 3-4: Return to Work
Please note that the above timeline is a general guideline and individual experiences might vary based on specific clinical situations. Always consult with your healthcare professional for personalized advice.
What patients like:
What patients don’t like:
Specializes in prostate cancer treatment with CyberKnife at Hisar Hospital Intercontinental – trained at Hacettepe University Cancer Institute.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Dr. Hasan Mutlu brings over a decade of specialized experience in medical oncology to CyberKnife treatments for prostate cancer.
Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.
He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.
CyberKnife for prostate cancer is a non-invasive treatment utilizing precision radiation therapy to target and treat prostate tumors.
CyberKnife is widely available for treating prostate cancer in Turkey at JCI-accredited oncology centers in Istanbul and Ankara. This non-surgical stereotactic body radiation therapy (SBRT) provides sub-millimeter precision for localized tumors. Patients often access latest-generation technology like the M6 Series with significantly shorter wait times than in the US.
Bookimed Expert Insight: While initial CyberKnife sessions are priced between $4,800 and $10,300, specialized prostate protocols typically range from $25,000 to $32,000. Data shows that top-tier clinics like Anadolu Medical Center benefit from direct affiliations with Johns Hopkins Medicine. These formal partnerships ensure that the robotic radiosurgery protocols used in Istanbul match the highest international standards for oncological care.
Patient Consensus: Many patients highlight the speed of care, starting treatment within 2 weeks of inquiry. They report minimal side effects and significant PSA drops within 6 months post-treatment.
CyberKnife success rates for localized prostate cancer in Turkey align with international standards, reporting 85% to 95% biochemical control over 5 years for low-to-intermediate risk cases. Leading Istanbul centers utilize robotic SBRT to deliver high-precision radiation, maintaining high survival rates while minimizing impact on surrounding healthy tissue.
Bookimed Expert Insight: Quality indicators in Turkey often exceed base expectations due to prestigious international affiliations. For instance, Anadolu Medical Center maintains a long-standing partnership with Johns Hopkins Hospital. This collaboration ensures that their radiation oncology protocols and success tracking follow rigorous US-based academic standards, offering clinical-grade reliability at a lower cost tier.
Patient Consensus: Patients value the significant savings but emphasize that follow-up care is vital. Many suggest verifying the specific 5-year recurrence data with Turkish clinics before traveling for treatment.
CyberKnife for prostate cancer typically requires 1 to 5 treatment sessions completed within 1 to 2 weeks. In contrast, conventional radiation therapy often involves 38 to 45 sessions delivered once daily over a period of 8 to 9 weeks.
Bookimed Expert Insight: While CyberKnife drastically reduces hospital visits, our data shows patients prioritize it for international travel. Clinics like Anadolu Medical Center and Medipol Mega University Hospital utilize CyberKnife specifically to condense treatment into a single 1-week trip, saving significant costs on long-term accommodation compared to 2-month conventional courses.
Patient Consensus: Patients value the condensed schedule to minimize time away from home, though many note that side effects tend to cluster intensely between days 3 and 7 after the final session.
CyberKnife for prostate cancer typically causes mild, temporary urinary urgency, increased frequency, or a burning sensation. These symptoms usually peak 3 to 4 weeks after treatment. Most patients return to normal activities within 1 to 3 days due to the precise, non-invasive robotic delivery.
Bookimed Expert Insight: Data from Anadolu Medical Center, a top-ranked facility affiliated with Johns Hopkins, shows high success with SBRT. Experts like Dr. Banu Atalar, trained at Stanford, emphasize that precision tracking minimizes rectal exposure. This explains why patients often avoid the long hospital stays required for traditional surgery.
Patient Consensus: Many patients find the fatigue less intense than expected compared to surgery. They recommend having medications like Flomax ready and staying hydrated to manage early urinary changes effectively.
Ideal candidates for CyberKnife in Turkey are patients with localized, small-to-medium tumors under 6 cm in sensitive or difficult-to-reach areas. This includes individuals with early-stage prostate cancer, Gleason scores of 7 or lower, and localized lesions in the lung, liver, or brain.
Bookimed Expert Insight: Turkish clinics often accept borderline intermediate-risk cases that US centers might reject. Facilities like Anadolu Medical Center utilize a 5-session protocol that costs $25,000 to $32,000. This is significantly lower than the $55,000 US average. Patients benefit from advanced M6 technology at around 48% savings while maintaining high potency preservation rates.
Patient Consensus: Many patients emphasize that prostate volume must be under 50cc to qualify for the procedure. They recommend getting a PSMA PET scan and a second opinion from 2–3 Turkish centers to confirm eligibility.
CyberKnife treatment for prostate cancer in Turkey is a non-invasive, outpatient procedure that does not require hospitalization. Patients receive robotic radiation therapy in 4 to 5 daily sessions lasting 30 to 90 minutes each, typically returning to their hotel immediately after every appointment.
Bookimed Expert Insight: While hospital stays are not medically necessary, clinics like Anadolu Medical Center and Memorial Bahcelievler offer all-inclusive logistics. Data shows these centers often bundle 4-star hotel stays and VIP transfers, as patients prefer resting in a hotel environment rather than a clinical ward between their 5 sessions.
Patient Consensus: Patients describe the recovery as feeling like mild workout soreness for about 2 weeks. Most appreciate the convenience of staying in nearby hotels which feels less stressful than a traditional hospital environment.